ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,800.78
-0.45%
Dow Jones
42,085.47
0.35%
US Dollar vs MXN
20.7598
0.23%
Brent Oil
80.31
-0.38%
Bitcoin
91,783.33
-2.86%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Vinci Partners Investments Ltd (VINP) Cotización

Vinci Partners Investments Ltd

Vinci Partners Investments Ltd (VINP)

NASDAQ
9.45
0.15
( 1.61% )
Actualizado: 11:27:14
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
9.45
Postura de Compra
9.42
Postura de Venta
9.47
Volume Operado de la Acción
22,414
9.19 Rango del Día 9.51
9.01 Rango de 52 semanas 11.85
Capitalización de Mercado [m]
612.983M
Precio Anterior
9.30
Precio de Apertura
9.19
Hora
1
@
9.449
Última hora de negociación
11:26:32
Volumen financiero
US$ 209,792
Precio Promedio Ponderado
9.3598
Volumen promedio (3 m)
77,548
Acciones en circulación
64,865,964
Rendimiento del Dividendo
6.77%
Ratio Precio/Utilidad
2.77
Beneficio por acción (BPA)
3.4
turnover
454.42M
Beneficio neto
220.61M

Acerca de Vinci Partners Investments Ltd

Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Market Strategies; Liquid Strategies; Investment Products and solutions AND Financial Advisory. The company's segment includes Private Market Strategies. Vinci Partners Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Market Strategies; Liquid Strategies; Investment Products and solutions AND Financial Advisory. The company's segment includes Private Market Strategies.

Sector
Investment Advice
Industria
Investment Advice
Sede
Rio De Janeiro, Rio De Janeiro, Bra
Fundado
-
Vinci Partners Investments Ltd is listed in the Investment Advice sector of the NASDAQ with ticker VINP. The last closing price for Vinci Partners Investments was US$9.30. Over the last year, Vinci Partners Investments shares have traded in a share price range of US$ 9.01 to US$ 11.85.

Vinci Partners Investments currently has 64,865,964 shares in issue. The market capitalisation of Vinci Partners Investments is US$603.25 million. Vinci Partners Investments has a price to earnings ratio (PE ratio) of 2.77.

VINP Últimas noticias

Más noticias

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

25 Noviembre 2024
Edgar (US Regulatory)

VINCI COMPASS TO HOST VIRTUAL WEBCAST TO DISCUSS COMBINATION TODAY AT 8:00AM ET

VINCI COMPASS TO HOST VIRTUAL WEBCAST TO DISCUSS COMBINATION TODAY AT 8:00AM ET PR Newswire RIO DE JANEIRO, Nov. 25, 2024 RIO DE JANEIRO, Nov. 25, 2024 /PRNewswire/ -- Vinci Partners Investments...

25 Noviembre 2024
PR Newswire (US)

Form 144 - Report of proposed sale of securities

12 Noviembre 2024
Edgar (US Regulatory)

VINCI PARTNERS TO HOST VIRTUAL WEBCAST TO DISCUSS COMBINATION WITH COMPASS ON NOVEMBER 25TH AT 8:00AM ET

VINCI PARTNERS TO HOST VIRTUAL WEBCAST TO DISCUSS COMBINATION WITH COMPASS ON NOVEMBER 25TH AT 8:00AM ET PR Newswire RIO DE JANEIRO, Nov. 11, 2024 RIO DE JANEIRO, Nov. 11, 2024 /PRNewswire/...

11 Noviembre 2024
PR Newswire (US)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

08 Noviembre 2024
Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

08 Noviembre 2024
Edgar (US Regulatory)

VINCI PARTNERS REPORTS THIRD QUARTER 2024 EARNINGS RESULTS

VINCI PARTNERS REPORTS THIRD QUARTER 2024 EARNINGS RESULTS PR Newswire RIO DE JANEIRO, Nov. 7, 2024 RIO DE JANEIRO, Nov. 7, 2024 /PRNewswire/ -- Vinci Partners Investments Ltd. (NASDAQ: VINP...

07 Noviembre 2024
PR Newswire (US)

Form 144 - Report of proposed sale of securities

06 Noviembre 2024
Edgar (US Regulatory)

Form SC 13D - General Statement of Acquisition of Beneficial Ownership

05 Noviembre 2024
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.48-4.833836858019.9310.0059.19898369.60121496CS
4-1.24-11.599625818510.6910.739.191020239.93120099CS
12-0.65-6.4356435643610.110.999.197754810.19619719CS
26-1.72-15.398388540711.1711.629.017442710.23012489CS
52-1.75-15.62511.211.859.015859810.46285463CS
156-2.97-23.913043478312.4214.577.75370710.40175573CS
260-8.25-46.610169491517.719.467.79060912.53287258CS

VINP - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Vinci Partners Investments?
El precio actual de las acciones de Vinci Partners Investments es US$ 9.45
¿Cuántas acciones de Vinci Partners Investments están en circulación?
Vinci Partners Investments tiene 64,865,964 acciones en circulación
¿Cuál es la capitalización de mercado de Vinci Partners Investments?
La capitalización de mercado de Vinci Partners Investments es USD 603.25M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Vinci Partners Investments?
Vinci Partners Investments ha negociado en un rango de US$ 9.01 a US$ 11.85 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Vinci Partners Investments?
El ratio precio/beneficio de Vinci Partners Investments es 2.77
¿Cuál es el ratio de efectivo a ventas de Vinci Partners Investments?
El ratio de efectivo a ventas de Vinci Partners Investments es 1.34
¿Cuál es la moneda de reporte de Vinci Partners Investments?
Vinci Partners Investments presenta sus resultados financieros en BRL
¿Cuál es el último ingresos anual de Vinci Partners Investments?
El último ingresos anual de Vinci Partners Investments es BRL 454.42M
¿Cuál es el último beneficio anual de Vinci Partners Investments?
El último beneficio anual de Vinci Partners Investments es BRL 220.61M
¿Cuál es la dirección registrada de Vinci Partners Investments?
La dirección registrada de Vinci Partners Investments es AV. BARTOLOMEU MITRE, 336, RIO DE JANEIRO, RIO DE JANEIRO, 22431-002
¿En qué sector industrial opera Vinci Partners Investments?
Vinci Partners Investments opera en el sector INVESTMENT ADVICE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
PHIOPhio Pharmaceuticals Corporation
US$ 6.47
(282.84%)
217.33M
SLRXSalarius Pharmaceuticals Inc
US$ 3.8855
(148.27%)
103.96M
ATPCAgape ATP Corporation
US$ 2.39
(89.68%)
74.61M
XXII22nd Century Group Inc
US$ 9.2178
(88.50%)
15.36M
VRMEVerifyMe Inc
US$ 4.3686
(71.32%)
33.53M
EHGOEshallgo Inc
US$ 1.10
(-66.36%)
2.53M
CMTLComtech Telecommunications Corporation
US$ 2.0601
(-50.12%)
2.98M
NAYANAYA Biosciences Inc
US$ 0.4912
(-39.61%)
729.9k
SVMHSRIVARU Holding Ltd
US$ 0.03755
(-39.24%)
129.11M
TCTMTCTM Kids IT Education Inc
US$ 0.457
(-37.79%)
751.73k
GCTKGlucoTrack Inc
US$ 0.1377
(17.69%)
603.16M
PHIOPhio Pharmaceuticals Corporation
US$ 6.47
(282.84%)
217.33M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0646
(-26.67%)
143.24M
SVMHSRIVARU Holding Ltd
US$ 0.03755
(-39.24%)
129.11M
NVDANVIDIA Corporation
US$ 132.56
(-2.46%)
124.55M

Discusión

Ver feed completo
wadirum1 wadirum1 5 minutos hace
The audit has apparently taken about 10 years longer than expected, no?

Is there some point at which we should all just confront Eric on his BS? Or do you think it is for the best to just continue as if the decade of missed deadlines was all just some random sequence of events that
HHSE
Hosai Hosai 5 minutos hace
Even if you read it as needing another trial which is obv up for debate (also would be for FDA - EMA clearly not), it would still mean Anavex have better and more robust long term trial data (3-4 years) compared to any AD phase 2 previously done by a company.
Eli Lily jumped $15.3 billion (
AVXL
BarrellofHay BarrellofHay 5 minutos hace
Company alluded to a Phase 4.

"A phase 4 clinical trial, also known as a post-marketing surveillance trial, is a study that examines a drug's safety and effectiveness after it has been approved and is available for patients."

Key is that this is a study used afte
AVXL
gp22 gp22 5 minutos hace
$MITQ @ 70s: ..Volume elevating....Last of the AI microfloats yet to rip.
MITQ
BottomBounce BottomBounce 5 minutos hace
$NIO Book Value Per Share (mrq) $12.43 Total Cash (mrq) $36.27B
NIO
I-Glow I-Glow 5 minutos hace
That is why you are underwater on Spooz because you believe anything Spooz posts on X as true and factual. LOLOL!

Spooz
@SpoozInc
2h
$SPZI The increase in the Authorized Shares is to secure potential acquisitions and to support the culmination of the commodity and
SPZI
gp22 gp22 5 minutos hace
$MITQ @ 70s: ..Volume elevating....Last of the AI microfloats yet to rip.
MITQ
Hi_Lo Hi_Lo 6 minutos hace
You haven't stopped anything and you never will
I'm not trying to stop anything. Unlike you and your lying pumps that helps and furthers this scam, I'm simply warning people here with documentation that this is a scam and that Jake P. Noch has a history of perpetrating huge frauds - including
BCAP
Strukture Strukture 6 minutos hace
VRME for the win today!
VRME
doc2016 doc2016 6 minutos hace
emPath ....thinking nvidia now hiring asic engineers in taiwan. i wonder why china wants more influence in taiwan? asics and fpga; asics and memristors, which remembering em state can go to tha switching /gate position..with soft fabric and software stacks and api's with the emPath information....
IONQ
martyDg martyDg 6 minutos hace
If I were a betting person, I would bet that mRESVIA and DCVax-L will be among the drugs that are approved by MHRA in January.


Who's going tell him he's about to be wrong? Maybe, try February, March, April and so on. 😝
NWBO
Zorax Zorax 6 minutos hace
Trying wash trading to look like interest again? Lots of beneficial ownership shenanigans as usual. Tax write offs anyone?
UEEC
scortech scortech 6 minutos hace
I doubt same "Person". Buys are making MM's buy their shorts back
Did good slap an ask they'll lose their shorts and show their A$$
JMO.
CGAC
Investor2014 Investor2014 6 minutos hace
The ability of Anavex snatching defeat from the claws of victory is uncanny!
AVXL
BCCHoosier BCCHoosier 6 minutos hace
Spot on. We have used a few bullets already and going nowhere. If we do get bought out it will be for far less than any of us expected.
AVXL
jpike jpike 7 minutos hace
I now have the largest position in Pays that I have held in years. Looking forward to large gains in the next year or two on this one.
PAYS
peanutz peanutz 7 minutos hace
If you are depending on that it's ashame . You are in the wrong business.
IGPK
hedge_fun hedge_fun 7 minutos hace
Jeff if you recall, there was a promo…….

group that talked about the OS reduction through a Preferred offering about 2 years ago. It was when the pps ran up to around half a penny.

Then they dumped and stopped pumping.

But they mentioned it in a podcast
APRU
arachnodude arachnodude 7 minutos hace
You asked...

How many trolls like Slinger spend their days obsessively spreading cherry-picked, manipulated nonsense, ignoring facts, and attacking progress just to get a rise out of others? Unfortunately, the answer to that is: far too many.

🤣🤣🤣
KBLB
Zenos Arrow Zenos Arrow 7 minutos hace
I’m sure he’s still there Loc. Why would he leave – he’s still getting paid? The bigger question is, has he done enough to satisfy his six-month incentive metrics. If so, we should get an 8-K announcing that 500K more shares were granted via meeting these metrics. So, no communication forthcoming co
HDVY
Gator44 Gator44 7 minutos hace
https://ih.advfn.com/stock-market/NASDAQ/sana-biotechnology-SANA/stock-news/95237254/form-8-k-current-report
SANA
Mojocash Mojocash 8 minutos hace
Averaged down for a rainy day!
HLLK
linkvest linkvest 8 minutos hace
Eat those freakin awesome 5s up newbies. They are so cheap for a quality company that has so much on the horizon and about to explode any time now.
ASII
zab zab 8 minutos hace
https://www.yahoo.com/news/maga-republican-slammed-saying-california-003138819.html

Once again, Republicans from California, let's not pay for anything.

Su Consulta Reciente

NASDAQ
VINP
Vinci Partners Investments
LSE
SG29
Hsbc Bk. 24
LSE
73YB
Granite Mas.a3a
UNSW
HHETH
Mover
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados